The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents.
- DOI
- 10.1186/s40478-021-01134-5
- Published
- 2021 Mar 4
- Container
- Acta neuropathologica communications
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s40478-021-01134-5,
title = {The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents.},
author = {Siller S and Lauseker M and Karschnia P and Niyazi M and Eigenbrod S and Giese A and Tonn JC},
year = {2021},
journal = {Acta neuropathologica communications},
doi = {10.1186/s40478-021-01134-5},
url = {https://doi.org/10.1186/s40478-021-01134-5}
}RIS
TY - JOUR TI - The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents. AU - Siller S AU - Lauseker M AU - Karschnia P AU - Niyazi M AU - Eigenbrod S AU - Giese A AU - Tonn JC PY - 2021 JO - Acta neuropathologica communications DO - 10.1186/s40478-021-01134-5 UR - https://doi.org/10.1186/s40478-021-01134-5 ER -
APA
S, S., M, L., P, K., M, N., S, E., A, G., & JC, T. (2021). The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents.. Acta neuropathologica communications. https://doi.org/10.1186/s40478-021-01134-5
Source records
- pubmed · retrieved 2026-09-26T03:25:13.830Z